Related Experiment Video
Updated: Aug 5, 2026
05:12
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
Published on: May 12, 2023
[Treatment of hyperthyroidism from Graves-Basedow's disease]
M C López Rey1, M Aguilar Diosdado, A García Curiel
1Departamento de Medicina Interna, Hospital Universitario Puerta del Mar, Facultad de Medicina, Universidad de Cádiz.
Anales De Medicina Interna (Madrid, Spain : 1984)
|May 1, 1993
Summary
Graves' disease treatment outcomes vary. Synthetic antithyroids show lower remission and higher recurrence rates compared to surgery or radioactive iodine for hyperthyroidism management.
Area of Science:
- Endocrinology
- Thyroidology
Context:
- Graves' disease is the leading cause of hyperthyroidism.
- Therapeutic options include antithyroids, radioactive iodine, and surgery.
- Consensus on optimal treatment is lacking.
Purpose:
- To compare the efficacy of synthetic antithyroids, surgery, and radioactive iodine in treating Graves' disease.
- To identify predictors of remission and recurrence in patients treated with antithyroids.
Summary:
- A study analyzed 217 Graves' disease patients: 96 on antithyroids, 46 surgery, 75 radioactive iodine.
- Antithyroid therapy achieved 67% remission, predicted by absence of ophthalmopathy. Recurrence (33/64) predicted by hormone levels.
- Surgery and radioactive iodine controlled hyperthyroidism in 91% and 100% of patients, respectively.
Impact:
- Findings suggest a more aggressive management approach for Graves' disease patients on synthetic antithyroids.
- Highlights the need for individualized treatment strategies based on patient factors and therapeutic outcomes.
- Contributes to understanding long-term efficacy and recurrence patterns of different hyperthyroidism treatments.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...